NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

11220	Companies
248798	Keywords
176588	Articles
134631	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 07/07/2025 at 22:15, 1 year 3 months ago

NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3)
Nanobiotix announces regulatory harmonization and new composition of matter patent filed for JNJ-1900 (NBTXR3), aiming to reinforce global positioning of potential first-in-class radioenhancer

NANOBIOTIX JNJ-1900 Global Positioning Regulatory Harmonization Composition Of Matter Patent
BRIEF

published on 06/24/2025 at 12:39, 1 year 3 months ago

Goldman Sachs franchit un seuil de participation dans Nanobiotix

Franchissement De Seuil Acquisition D'actions Marché Boursier Goldman Sachs NANOBIOTIX
BRIEF

published on 06/24/2025 at 12:39, 1 year 3 months ago

Goldman Sachs Crosses Stake Threshold in Nanobiotix

Stock Market Acquisition Of Shares Goldman Sachs Threshold Crossing NANOBIOTIX
PRESS RELEASE

published on 06/24/2025 at 12:34, 1 year 3 months ago

Franchissement de seuils
Déclaration de franchissement de seuils par The Goldman Sachs Group, Inc. concernant NANOBIOTIX, une société cotée sur Euronext Paris

Euronext Paris The Goldman Sachs Group, Inc. Franchissement De Seuils Déclaration AMF Actions NANOBIOTIX
BRIEF

published on 06/10/2025 at 22:20, 1 year 4 months ago

Nombre d'Actions et Droits de Vote de Nanobiotix

Euronext Paris Droits De Vote Actions Nasdaq NANOBIOTIX
BRIEF

published on 06/10/2025 at 22:20, 1 year 4 months ago

Number of Shares and Voting Rights of Nanobiotix

Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 06/10/2025 at 22:15, 1 year 4 months ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Publication mensuelle des droits de vote et actions de Nanobiotix, société de biotechnologie en phase clinique et avancée cotée sur Euronext Paris et le Nasdaq. Informations détaillées sur www.nanobiotix.com

Euronext Paris Biotechnologie Nasdaq NANOBIOTIX Physique
PRESS RELEASE

published on 06/10/2025 at 22:15, 1 year 4 months ago

Voting Rights and Shares Capital of the Company
Nanobiotix discloses voting rights and shares capital. The company is a biotechnology pioneer with disruptive therapeutic approaches. Visit www.nanobiotix.com for more info

Voting Rights Biotechnology Shares Capital NANOBIOTIX Therapeutic Approaches
BRIEF

published on 05/21/2025 at 22:20, 1 year 5 months ago

Nanobiotix Reports Q1 2025 Achievements and Financial Status

Biotechnology Financial Update NANOBIOTIX JNJ-1900 Cancer Trials
BRIEF

published on 05/21/2025 at 22:20, 1 year 5 months ago

Nanobiotix publie ses résultats et sa situation financière pour le premier trimestre 2025

Biotechnologie Mise À Jour Financière NANOBIOTIX JNJ-1900 Essais Sur Le Cancer

Accesswire

Published on 10/23/2026 at 02:20, 9 hours 38 minutes ago

Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 12 hours 28 minutes ago

Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 13 hours 28 minutes ago

Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 19 hours 58 minutes ago

Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 21 hours 28 minutes ago

Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components

View all ACCESSWIRE

EQS Group

Published on 10/23/2026 at 11:45, 13 minutes ago

Original-Research: Grand City Properties SA (von First Berlin Equity Research GmbH): Kaufen
Published on 10/23/2026 at 11:30, 28 minutes ago

Bulgarian Financial Supervision Commission completes preliminary review of the voluntary public takeover offer for Shelly Group SE
Published on 10/23/2026 at 11:30, 28 minutes ago

Acceptance period of Sazerac’s voluntary public takeover offer for Berentzen-Gruppe Aktiengesellschaft commences
Published on 10/23/2026 at 11:00, 58 minutes ago

Annual General Meeting Approves Contribution: Innok Robotics on Course for the Public Capital Market
Published on 10/23/2026 at 10:58, 59 minutes ago

How can digitalization improve healthcare?

Les Echos

Published on 10/23/2026 at 07:00, 4 hours 58 minutes ago

Safran reports third quarter 2026 revenue
Published on 10/23/2026 at 07:00, 4 hours 58 minutes ago

Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 17 hours 58 minutes ago

THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 17 hours 58 minutes ago

THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 17 hours 58 minutes ago

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics

View all LES ECHOS COMFI WIRE